516
Views
1
CrossRef citations to date
0
Altmetric
Clinical

Fatigue and anxiety mediate the effect of dyspnea on quality of life in amyotrophic lateral sclerosis

, , ORCID Icon, , ORCID Icon, , , & show all
Pages 390-398 | Received 13 Apr 2021, Accepted 28 Sep 2021, Published online: 28 Oct 2021

References

  • Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
  • Kurian KM, Forbes RB, Colville S, Swingler RJ. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry. 2009;80:84–7.
  • Abdulla S, Vielhaber S, Kollewe K, Machts J, Heinze HJ, Dengler R, et al. The impact of physical impairment on emotional well-being in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:392–7.
  • Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol. 2006;5:140–7.
  • Butz M, Wollinsky KH, Wiedemuth-Catrinescu U, Sperfeld A, Winter S, Mehrkens HH, et al. Longitudinal effects of noninvasive positive-pressure ventilation in patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2003;82:597–604.
  • Dorst J, Behrendt G, Ludolph AC. Non-invasive ventilation and hypercapnia-associated symptoms in amyotrophic lateral sclerosis. Acta Neurol Scand. 2019;139:128–34.
  • Morelot-Panzini C, Perez T, Sedkaoui K, de Bock E, Aguilaniu B, Devillier P, et al. The multidimensional nature of dyspnoea in amyotrophic lateral sclerosis patients with chronic respiratory failure: Air hunger, anxiety and fear. Respir Med. 2018;145:1–7.
  • Young CA, Ealing J, McDermott C, Williams T, Al-Chalabi A, Majeed T, et al. The relationships between symptoms, disability, perceived health and quality of life in amyotrophic lateral sclerosis/motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 2019;20(5-6):317–327.
  • Edge R, Mills R, Tennant A, Diggle PJ, Young CA, TONiC study groupDo pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature. J Neurol. 2020;267:607–15.
  • Shamshiri H, Fatehi F, Abolfazli R, Harirchian MH, Sedighi B, Zamani B, et al. Trends of quality of life changes in amyotrophic lateral sclerosis patients. J Neurol Sci. 2016;368:35–40.
  • Neuman A, Gunnbjörnsdottir M, Tunsäter A, Nyström L, Franklin KA, Norrman E, et al. Dyspnea in relation to symptoms of anxiety and depression: a prospective population study. Respir Med. 2006;100:1843–9.
  • Gysels MH, Higginson IJ. The lived experience of breathlessness and its implications for care: a qualitative comparison in cancer, COPD, heart failure and MND. BMC Palliat Care. 2011;10:15.
  • Oh H, Sin MK, Schepp KG, Choi-Kwon S. Depressive symptoms and functional impairment among amyotrophic lateral sclerosis patients in South Korea. Rehabil Nurs. 2012;37:136–44.
  • Körner S, Kollewe K, Abdulla S, Zapf A, Dengler R, Petri S. Interaction of physical function, quality of life and depression in amyotrophic lateral sclerosis: characterization of a large patient cohort. BMC Neurol. 2015;15:84.
  • Atassi N, Cook A, Pineda CM, Yerramilli-Rao P, Pulley D, Cudkowicz M. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:109–12.
  • Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, WFN Research Group On ALS/MND, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:291–2.
  • Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the dyspnoea-12. Thorax 2010;65:21–6.
  • Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Development of a patient reported outcome measure for fatigue in motor neurone disease: the Neurological Fatigue Index (NFI-MND). Health Qual Life Outcomes. 2011;9:101.
  • Franchignoni F, Mora G, Giordano A, Volanti P, Chio A. Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. J Neurol Neurosurg Psychiatry. 2013;84:1340–5.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361–70.
  • Gibbons CJ, Mills RJ, Thornton EW, Ealing J, Mitchell JD, Shaw PJ, et al. Rasch analysis of the hospital anxiety and depression scale (HADS) for use in motor neurone disease. Health Qual Life Outcomes. 2011;9:82–90.
  • The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998;28:551–8.
  • Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: University of Chicago Press; 1960.
  • Masters G. A Rasch model for partial credit scoring. Psychometrika 1982;47:149–74.
  • Christensen KB, Makransky G, Horton M. Critical values for Yen's Q3: identification of local dependence in the rasch model using residual correlations. Appl Psychol Meas. 2017;41:178–94.
  • Thissen D, Steinberg L, Mooney JA. Trace lines for testlets: a use of multiple‐categorical‐response models. J Educ Measure. 1989;26:247–60.
  • Rouquette A, Hardouin JB, Vanhaesebrouck A, Sébille V, Coste J. Differential Item Functioning (DIF) in composite health measurement scale: recommendations for characterizing DIF with meaningful consequences within the Rasch model framework. PLoS One. 2019;14:e0215073.
  • Hayduk L. Structural equation modeling with LISREL: Essentials and advances. Baltimore, USA: Johns Hopkins University Press; 1987.
  • Kline R. Principles and practice of structural equation modeling. Fourth Edition ed. New York, London: Guilford Press; 2015.
  • Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59–65.
  • Milinis K, Tennant A, Mills RJ, Al-Chalabi A, Burke G, Dick DJ, the TONiC study group, et al. Development and validation of Spasticity Index-Amyotrophic Lateral Sclerosis. Acta Neurol Scand. 2018;138:47–54.
  • Lou JS, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 2003;60:122–3.
  • Chio A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol 2017;16:144–57.
  • Sandstedt P, Johansson S, Ytterberg C, Ingre C, Holmqvist LW, Kierkegaard M. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci. 2016;370:269–73.
  • van Groenestijn AC, Kruitwagen-van Reenen ET, Visser-Meily JM, van den Berg LH, Schroder CD. Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review. Health Qual Life Outcomes. 2016;14:107.
  • Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37:336–42.
  • Bakas T, McLennon SM, Carpenter JS, Buelow JM, Otte JL, Hanna KM, et al. Systematic review of health-related quality of life models. Health Qual Life Outcomes. 2012;10:134.
  • Herigstad M, Hayen A, Wiech K, Pattinson KT. Dyspnoea and the brain. Respir Med. 2011;105:809–17.
  • Pattinson KT, Turner MR. A wider pathological network underlying breathlessness and respiratory failure in amyotrophic lateral sclerosis. Eur Respir J. 2016;47:1632–4.
  • Herigstad M, Hayen A, Evans E, Hardinge FM, Davies RJ, Wiech K, et al. Dyspnea-related cues engage the prefrontal cortex: evidence from functional brain imaging in COPD. Chest 2015;148:953–61.
  • Binks AP, Evans KC, Reed JD, Moosavi SH, Banzett RB. The time-course of cortico-limbic neural responses to air hunger. Respir Physiol Neurobiol. 2014;204:78–85.
  • Nichols NL, Van Dyke J, Nashold L, Satriotomo I, Suzuki M, Mitchell GS. Ventilatory control in ALS. Respir Physiol Neurobiol. 2013;189:429–37.
  • Seven YB, Mitchell GS. Mechanisms of compensatory plasticity for respiratory motor neuron death. Respir Physiol Neurobiol. 2019;265:32–9.
  • Vogt S, Schreiber S, Pfau G, Kollewe K, Heinze HJ, Dengler R, et al. Dyspnea as a fatigue-promoting factor in ALS and the role of objective indicators of respiratory impairment. J Pain Symptom Manage 2020;60(2):430-438.e1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.